News - Onglyza

Filter

Current filters:

Onglyza

Popular Filters

Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD

19-06-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) and US partner Bristol-Myers Squibb have announced mixed…

AstraZenecaBristol-Myers SquibbDiabetesNeurologicalNewron PharmaOnglyzaPharmaceuticalResearchsafinamideZambon

EC approves additional use for Bristol-Myers and AstraZeneca’s Onglyza and Komboglyze

29-11-2011

The European Commission has approved drug majors Bristol-Myers Squibb (NYSE: BMY) and AstraZeneca’s…

AstraZenecaBristol-Myers SquibbDiabetesEuropeKomboglyzeOnglyzaPharmaceuticalResearch

Highlights from American Diabetes Association meeting

27-06-2011

There was a batch of good news coming out of the American Diabetes Association (ADA) 71st annual scientific…

ApidraAstraZenecaBristol-Myers SquibbdapagliflozinDiabetesLantusLyxumiaNovo NordiskOnglyzaPharmaceuticalResearchSanofiVictoza

Company Spotlight

Fibrotech

Fibrotech

Back to top